Comment on With Ardelyx's Fall, Does Synergy Now Have a Clear Path to Victory?

With Ardelyx's Fall, Does Synergy Now Have a Clear Path to Victory?

Shares of Ardelyx (NASDAQ: ARDX) are hitting a new all-time low  following the results of a "positive" phase 3 trial read out earlier this month. While shares of competitor Synergy Pharmaceuticals (NASDAQ: SGYP) saw a slight increase the day of Ardelyx's announcement, Synergy has fared little better, with shares down almost to their lowest point this year.ARDX data by YChartsContinue reading

 

Comment On This Story

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News